AUTOIMMUNE DISEASES

This early-stage study tested a new cell therapy called VCTX211 in 5 people with long-standing type 1 diabetes. The goal was to see if the implanted cells could safely help the body produce its own insulin again. The trial was stopped early, and results are not yet available.

This study tested a drug called peresolimab in adults with moderate to severe rheumatoid arthritis, a condition causing joint pain and swelling. The goal was to see if the drug safely improves symptoms like tender and swollen joints. The trial was stopped early, but results may s…

This study tested whether adding melatonin to a standard MS drug (ocrelizumab) could slow disability in people with progressive multiple sclerosis. The trial was stopped early after enrolling only 25 participants. It aimed to measure changes in walking, arm function, and thinking…

This study aimed to see if naproxen sodium, a common anti-inflammatory drug, could reduce obsessive-compulsive symptoms in children with PANDAS, a condition linked to strep infections. The trial planned to enroll children aged 6 to 15 with new-onset OCD, but was terminated early …

This study looked at how well the COVID-19 vaccine triggers an immune response in people with autoimmune or inflammatory diseases who take medications that suppress the immune system. Researchers measured antibodies and T-cells after vaccination in 78 adults. The goal was to unde…